ClinConnect ClinConnect Logo
Search / Trial NCT05910840

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Launched by ANNE-SOPHIE BRAZEAU · Jun 16, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Transition Care Pediatric Adolescent Education Hemaglobin A1c Self Management Randomized Controlled Trial

ClinConnect Summary

This clinical trial is looking at how an online training and peer support platform, called Support-t, can help teenagers with Type 1 Diabetes (T1D) prepare for the transition to adult healthcare. The study involves 14-16 year-olds who are receiving diabetes care at specific pediatric diabetes clinics in Quebec. Researchers want to see if using this online program, along with their usual care, can lead to better health outcomes, like improved blood sugar control and overall well-being, compared to just receiving usual care alone.

To participate in this study, young people need to be diagnosed with Type 1 Diabetes, be between 14 and 16 years old, have internet access, and be fluent in either English or French. They will be asked to engage with the online platform and attend regular follow-up appointments. It's important to note that those with severe cognitive disabilities or certain blood conditions that affect test results won't be eligible. Participants will have the chance to learn more about managing their diabetes while also connecting with peers who are going through similar experiences.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adolescents with a clinical diagnosis of T1D
  • 14-16 years of age
  • Receiving diabetes care at one of 4 university teaching hospital-based pediatric diabetes clinics in Quebec: Montreal Children's Hospital-McGill University Health Centre, Centre hospitalier universitaire de Sherbrooke, Le Copain-Hôpital de Gatineau, Centre Hospitalier Universitaire de Québec
  • Having access to internet
  • Having an active email address
  • Fluent in English or French
  • Exclusion Criteria:
  • Severe neurocognitive disabilities
  • Patients with conditions associated with shortened erythrocyte survival, such as hemolytic anemia or other conditions associated with inaccurate HbA1c

About Anne Sophie Brazeau

Anne-Sophie Brazeau is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the healthcare sector, she focuses on innovative therapeutic solutions and the efficient management of clinical trials. Her leadership emphasizes ethical practices, regulatory compliance, and collaboration with multidisciplinary teams to ensure high-quality research standards. Through her initiatives, Brazeau aims to foster a dynamic environment that accelerates the development of groundbreaking treatments, ultimately contributing to the betterment of public health.

Locations

Sherbrooke, , Canada

Québec, , Canada

Gatineau, , Canada

Montréal, , Canada

Patients applied

0 patients applied

Trial Officials

Anne-Sophie Brazeau, PhD

Principal Investigator

School of Human Nutrition - McGill University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported